Immunome Inc. (IMNM) stock
IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$18.77+0.07 (+0.37%)
Close on Nov 13, 2026Market cap $2.13BP/E –Yield –
Immunome cash
Cash and short-term investments held at the end of each period.
Immunome's cash was $461.58M at Sep 30, 2026. For fiscal 2025 it was $653.48M, up 200.6% from the year before. The highest annual figure on record is $653.48M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $653.48M | +200.6% |
| FY2024 | Dec 31, 2024 | $217.40M | +57.3% |
| FY2023 | Dec 31, 2023 | $138.24M | +576.9% |
| FY2022 | Dec 31, 2022 | $20.42M | -58.6% |
| FY2021 | Dec 31, 2021 | $49.33M | +23.7% |
| FY2020 | Dec 31, 2020 | $39.87M | +1408.4% |
| FY2019 | Dec 31, 2019 | $2.64M | +55.3% |
| FY2018 | Dec 31, 2018 | $1.70M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $461.58M | +72.2% |
| Q1 FY2026 | Mar 31, 2026 | $582.69M | +83.6% |
| Q4 FY2025 | Dec 31, 2025 | $653.48M | +200.6% |
| Q3 FY2025 | Sep 30, 2025 | $272.64M | +13.5% |
| Q2 FY2025 | Jun 30, 2025 | $268.04M | -3.7% |
| Q1 FY2025 | Mar 31, 2025 | $317.32M | +2.5% |
| Q4 FY2024 | Dec 31, 2024 | $217.40M | +57.3% |
| Q3 FY2024 | Sep 30, 2024 | $240.13M | +164.9% |
| Q2 FY2024 | Jun 30, 2024 | $278.35M | +624.6% |
| Q1 FY2024 | Mar 31, 2024 | $309.71M | +597.2% |
| Q4 FY2023 | Dec 31, 2023 | $138.24M | +576.9% |
| Q3 FY2023 | Sep 30, 2023 | $90.64M | +234.7% |
| Q2 FY2023 | Jun 30, 2023 | $38.42M | +10.9% |
| Q1 FY2023 | Mar 31, 2023 | $44.42M | +3.6% |
| Q4 FY2022 | Dec 31, 2022 | $20.42M | -58.6% |
| Q3 FY2022 | Sep 30, 2022 | $27.08M | -51.9% |
| Q2 FY2022 | Jun 30, 2022 | $34.65M | -42.1% |
| Q1 FY2022 | Mar 31, 2022 | $42.88M | +17.9% |
| Q4 FY2021 | Dec 31, 2021 | $49.33M | +23.7% |
| Q3 FY2021 | Sep 30, 2021 | $56.24M | +734.0% |
| Q2 FY2021 | Jun 30, 2021 | $59.83M | +511.2% |
| Q1 FY2021 | Mar 31, 2021 | $36.38M | +2559.1% |
| Q4 FY2020 | Dec 31, 2020 | $39.87M | +1408.4% |
| Q3 FY2020 | Sep 30, 2020 | $6.74M | +684.2% |
| Q2 FY2020 | Jun 30, 2020 | $9.79M | +475.1% |
| Q1 FY2020 | Mar 31, 2020 | $1.37M | – |
| Q4 FY2019 | Dec 31, 2019 | $2.64M | – |
| Q3 FY2019 | Sep 30, 2019 | $860.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $1.70M | – |
See a number that looks wrong?